Chinese Journal of Oncology Prevention and Treatment ›› 2011, Vol. 3 ›› Issue (2): 117-.doi: 10.3969/j.issn.1674-5671.2011.02.06
Previous Articles Next Articles
WEI Chang-Yuan, LI Ting, YAO Bo, QIN Qing-Hong, YANG Wei-Ping, HUANG Bai-Sha, MO Kai-Di
Online:
Published:
Abstract: 【Abstract】Objective To evaluate the clinical efficacy of permanent implantation of iodine 125 (I125) seed combined with surgical operation,chemotherapy,interventional therapy,immunization therapy and endocrine therapy on the patients with advanced breast cancer. Methods Permanent implantation of I125 seed combined with surgical operation,chemotherapy,interventional therapy,immunization therapy and endocrine therapy were performed on 95 cases of advanced breast cancer. The effective rate as well as the 1-,3- and 5-year survival rate were followed up. Results The effective rate was 96.84%. The 1-,3- and 5-year survival rate was 90.53%,61.05% and 46.32% respectively. 4 cases died from non-cancer,8 cases lost in follow-up. No associated complications were foundConclusion permanent implantation of I125 seed is safe and effective for treating advanced breast cancer.
Key words: 【Key words】I125seed, Advanced breast cancer, Implantation, Comprehensive therapy 【Key words】I125seed 【Key words】I125seed, Advanced breast cancer, Implantation, Comprehensive therapy
WEI Chang-Yuan, LI Ting, YAO Bo, QIN Qing-Hong, YANG Wei-Ping, HUANG Bai-Sha, MO Kai-Di. [J].Chinese Journal of Oncology Prevention and Treatment, 2011, 3(2): 117-.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://www.zgazfz.com/EN/10.3969/j.issn.1674-5671.2011.02.06
http://www.zgazfz.com/EN/Y2011/V3/I2/117
Cited